Erythropoietin/EPO Antibody (EPO/3793R) [Janelia Fluor® 585]

Product Discontinued

Erythropoietin/EPO Antibody (EPO/3793R) [Janelia Fluor® 585] Summary

• Additional Information: Recombinant Monoclonal Antibody
• Immunogen: Recombinant fragment (around aa 28-162) of human Erythropoietin/EPO protein (exact sequence is proprietary) (Uniprot: P01588)
• Localization: Cytoplasmic and Cell Surface
• Marker: Marker of Placentation Disorders
• Isotype: IgG
• Clonality: Monoclonal
• Host: Rabbit
• Gene: EPO
• Purity: Protein A or G purified

Applications/Dilutions

• Dilutions:
  • ELISA
  • Immunohistochemistry-Paraffin
• Application Notes: Optimal dilution of this antibody should be experimentally determined.

Packaging, Storage & Formulations

• Storage: Store at 4C in the dark.
• Buffer: 50mM Sodium Borate
• Preservative: 0.05% Sodium Azide
• Purity: Protein A or G purified

Notes

Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.

Alternate Names for Erythropoietin/EPO Antibody (EPO/3793R) [Janelia Fluor® 585]

• ECYT5
• EP
• EPO
• epoetin
• Erythropoietin
• MGC138142
• MVCD2

Background

Erythropoietin (Epo) stimulates red blood cell production by docking with its cognate receptor on the erythroid progenitor cell and triggering an array of signaling pathways that inhibit apoptosis and promote cell proliferation and differentiation. In its pharmaceutical forms, epoetin and darbepoetin, Epo is widely used to treat various anemias, including those associated with cancer.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Bioinformatics

• Gene Symbol: EPO